HEADER VIRAL PROTEIN/INHIBITOR 28-NOV-12 4I54 TITLE CRYSTAL STRUCTURE OF CLADE A/E 93TH057 HIV-1 GP120 H375S CORE IN TITLE 2 COMPLEX WITH DMJ-II-121 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIV-1 GLYCOPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: A/E 93TH057; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: 293F; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVRC8400 KEYWDS HIV, GP120, ENTRY INHIBITOR, STRUCTURE-BASED DRUG DESIGN, KEYWDS 2 THERMODYNAMICS, VIRAL INHIBITION, DMJ-II-121, CD4-MIMETIC, VIRAL KEYWDS 3 PROTEIN-INHIBITOR COMPLEX, CLADE A/E, CD4, EXTRACELLULAR EXPDTA X-RAY DIFFRACTION AUTHOR M.LE-KHAC,W.A.HENDRICKSON REVDAT 3 26-MAY-21 4I54 1 SOURCE HETSYN REVDAT 2 29-JUL-20 4I54 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE REVDAT 1 29-MAY-13 4I54 0 JRNL AUTH J.M.LALONDE,M.LE-KHAC,D.M.JONES,J.R.COURTER,J.PARK,A.SCHON, JRNL AUTH 2 A.M.PRINCIOTTO,X.WU,J.R.MASCOLA,E.FREIRE,J.SODROSKI, JRNL AUTH 3 N.MADANI,W.A.HENDRICKSON,A.B.SMITH JRNL TITL STRUCTURE-BASED DESIGN AND SYNTHESIS OF AN HIV-1 ENTRY JRNL TITL 2 INHIBITOR EXPLOITING X-RAY AND THERMODYNAMIC JRNL TITL 3 CHARACTERIZATION. JRNL REF ACS MED CHEM LETT V. 4 338 2013 JRNL REFN ISSN 1948-5875 JRNL PMID 23667716 JRNL DOI 10.1021/ML300407Y REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 28519 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1457 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.6308 - 5.3796 0.98 2814 151 0.1669 0.2223 REMARK 3 2 5.3796 - 4.2727 0.99 2754 149 0.1568 0.2085 REMARK 3 3 4.2727 - 3.7334 0.93 2590 138 0.1831 0.2229 REMARK 3 4 3.7334 - 3.3924 0.90 2458 152 0.2032 0.2792 REMARK 3 5 3.3924 - 3.1494 1.00 2748 151 0.2160 0.3202 REMARK 3 6 3.1494 - 2.9639 1.00 2751 137 0.2199 0.3632 REMARK 3 7 2.9639 - 2.8155 1.00 2787 135 0.2302 0.2927 REMARK 3 8 2.8155 - 2.6930 0.99 2722 147 0.2452 0.3296 REMARK 3 9 2.6930 - 2.5894 0.99 2702 155 0.2659 0.3162 REMARK 3 10 2.5894 - 2.5000 0.99 2736 142 0.2880 0.3657 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.400 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5778 REMARK 3 ANGLE : 1.222 7827 REMARK 3 CHIRALITY : 0.075 904 REMARK 3 PLANARITY : 0.005 984 REMARK 3 DIHEDRAL : 17.336 2163 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4I54 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076315. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979180 REMARK 200 MONOCHROMATOR : CRYOGENICALLY-COOLED SINGLE REMARK 200 CRYSTAL SI(111) SIDE BOUNCE REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40186 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.205 REMARK 200 RESOLUTION RANGE LOW (A) : 94.432 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.21 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 74.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 8000, 5% ISO-PROPANOL, 0.1M REMARK 280 HEPES 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K, PH REMARK 280 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.38750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 318 REMARK 465 GLY A 319 REMARK 465 SER A 320 REMARK 465 GLY A 321 REMARK 465 SER A 322 REMARK 465 GLY A 323 REMARK 465 GLY A 403 REMARK 465 ASN A 404 REMARK 465 GLU A 405 REMARK 465 THR A 406 REMARK 465 MET A 407 REMARK 465 LYS A 408 REMARK 465 GLY A 409 REMARK 465 CYS A 410 REMARK 465 GLY B 318 REMARK 465 GLY B 319 REMARK 465 SER B 320 REMARK 465 GLY B 321 REMARK 465 SER B 322 REMARK 465 GLY B 323 REMARK 465 GLY B 403 REMARK 465 ASN B 404 REMARK 465 GLU B 405 REMARK 465 THR B 406 REMARK 465 MET B 407 REMARK 465 LYS B 408 REMARK 465 GLY B 409 REMARK 465 CYS B 410 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 204 157.99 -48.94 REMARK 500 CYS A 205 63.22 -161.07 REMARK 500 ASP A 211 103.60 -166.47 REMARK 500 GLN A 258 -55.20 79.15 REMARK 500 GLU A 268 -90.39 -121.26 REMARK 500 SER A 274 138.58 -170.67 REMARK 500 ASN A 276 97.96 -179.43 REMARK 500 SER A 365 -76.28 -70.18 REMARK 500 HIS A 374 98.98 -67.15 REMARK 500 PHE A 391 51.20 -118.25 REMARK 500 CYS A 395 20.91 -72.50 REMARK 500 ASN B 94 103.32 -162.76 REMARK 500 LEU B 122 72.45 -110.63 REMARK 500 ASP B 211 114.68 -162.14 REMARK 500 ASN B 232 64.93 -110.70 REMARK 500 LYS B 240 -82.38 -85.91 REMARK 500 ASN B 241 89.46 -56.68 REMARK 500 GLN B 258 -61.48 68.23 REMARK 500 GLU B 267 31.65 -79.61 REMARK 500 GLU B 268 -110.59 -172.48 REMARK 500 PHE B 353 50.73 -97.49 REMARK 500 LYS B 357 -156.49 -73.33 REMARK 500 ASN B 393 -5.89 -55.46 REMARK 500 CYS B 395 41.01 -107.54 REMARK 500 THR B 430 55.69 -94.14 REMARK 500 THR B 430 -55.27 60.32 REMARK 500 ALA B 460 38.66 -143.22 REMARK 500 REMARK 500 REMARK: NULL DBREF 4I54 A 44 492 PDB 4I54 4I54 44 492 DBREF 4I54 B 44 492 PDB 4I54 4I54 44 492 SEQRES 1 A 353 VAL TRP LYS ASP ALA ASP THR THR LEU PHE CYS ALA SER SEQRES 2 A 353 ASP ALA LYS ALA HIS GLU THR GLU VAL HIS ASN VAL TRP SEQRES 3 A 353 ALA THR HIS ALA CYS VAL PRO THR ASP PRO ASN PRO GLN SEQRES 4 A 353 GLU ILE HIS LEU GLU ASN VAL THR GLU ASN PHE ASN MET SEQRES 5 A 353 TRP LYS ASN ASN MET VAL GLU GLN MET GLN GLU ASP VAL SEQRES 6 A 353 ILE SER LEU TRP ASP GLN SER LEU GLN PRO CYS VAL LYS SEQRES 7 A 353 LEU THR GLY GLY SER VAL ILE LYS GLN ALA CYS PRO LYS SEQRES 8 A 353 ILE SER PHE ASP PRO ILE PRO ILE HIS TYR CYS THR PRO SEQRES 9 A 353 ALA GLY TYR VAL ILE LEU LYS CYS ASN ASP LYS ASN PHE SEQRES 10 A 353 ASN GLY THR GLY PRO CYS LYS ASN VAL SER SER VAL GLN SEQRES 11 A 353 CYS THR HIS GLY ILE LYS PRO VAL VAL SER THR GLN LEU SEQRES 12 A 353 LEU LEU ASN GLY SER LEU ALA GLU GLU GLU ILE ILE ILE SEQRES 13 A 353 ARG SER GLU ASN LEU THR ASN ASN ALA LYS THR ILE ILE SEQRES 14 A 353 VAL HIS LEU ASN LYS SER VAL GLU ILE ASN CYS THR ARG SEQRES 15 A 353 PRO SER ASN GLY GLY SER GLY SER GLY GLY ASP ILE ARG SEQRES 16 A 353 LYS ALA TYR CYS GLU ILE ASN GLY THR LYS TRP ASN LYS SEQRES 17 A 353 VAL LEU LYS GLN VAL THR GLU LYS LEU LYS GLU HIS PHE SEQRES 18 A 353 ASN ASN LYS THR ILE ILE PHE GLN PRO PRO SER GLY GLY SEQRES 19 A 353 ASP LEU GLU ILE THR MET HIS SER PHE ASN CYS ARG GLY SEQRES 20 A 353 GLU PHE PHE TYR CYS ASN THR THR GLN LEU PHE ASN ASN SEQRES 21 A 353 THR CYS ILE GLY ASN GLU THR MET LYS GLY CYS ASN GLY SEQRES 22 A 353 THR ILE THR LEU PRO CYS LYS ILE LYS GLN ILE ILE ASN SEQRES 23 A 353 MET TRP GLN GLY THR GLY GLN ALA MET TYR ALA PRO PRO SEQRES 24 A 353 ILE ASP GLY LYS ILE ASN CYS VAL SER ASN ILE THR GLY SEQRES 25 A 353 ILE LEU LEU THR ARG ASP GLY GLY ALA ASN ASN THR SER SEQRES 26 A 353 ASN GLU THR PHE ARG PRO GLY GLY GLY ASN ILE LYS ASP SEQRES 27 A 353 ASN TRP ARG SER GLU LEU TYR LYS TYR LYS VAL VAL GLN SEQRES 28 A 353 ILE GLU SEQRES 1 B 353 VAL TRP LYS ASP ALA ASP THR THR LEU PHE CYS ALA SER SEQRES 2 B 353 ASP ALA LYS ALA HIS GLU THR GLU VAL HIS ASN VAL TRP SEQRES 3 B 353 ALA THR HIS ALA CYS VAL PRO THR ASP PRO ASN PRO GLN SEQRES 4 B 353 GLU ILE HIS LEU GLU ASN VAL THR GLU ASN PHE ASN MET SEQRES 5 B 353 TRP LYS ASN ASN MET VAL GLU GLN MET GLN GLU ASP VAL SEQRES 6 B 353 ILE SER LEU TRP ASP GLN SER LEU GLN PRO CYS VAL LYS SEQRES 7 B 353 LEU THR GLY GLY SER VAL ILE LYS GLN ALA CYS PRO LYS SEQRES 8 B 353 ILE SER PHE ASP PRO ILE PRO ILE HIS TYR CYS THR PRO SEQRES 9 B 353 ALA GLY TYR VAL ILE LEU LYS CYS ASN ASP LYS ASN PHE SEQRES 10 B 353 ASN GLY THR GLY PRO CYS LYS ASN VAL SER SER VAL GLN SEQRES 11 B 353 CYS THR HIS GLY ILE LYS PRO VAL VAL SER THR GLN LEU SEQRES 12 B 353 LEU LEU ASN GLY SER LEU ALA GLU GLU GLU ILE ILE ILE SEQRES 13 B 353 ARG SER GLU ASN LEU THR ASN ASN ALA LYS THR ILE ILE SEQRES 14 B 353 VAL HIS LEU ASN LYS SER VAL GLU ILE ASN CYS THR ARG SEQRES 15 B 353 PRO SER ASN GLY GLY SER GLY SER GLY GLY ASP ILE ARG SEQRES 16 B 353 LYS ALA TYR CYS GLU ILE ASN GLY THR LYS TRP ASN LYS SEQRES 17 B 353 VAL LEU LYS GLN VAL THR GLU LYS LEU LYS GLU HIS PHE SEQRES 18 B 353 ASN ASN LYS THR ILE ILE PHE GLN PRO PRO SER GLY GLY SEQRES 19 B 353 ASP LEU GLU ILE THR MET HIS SER PHE ASN CYS ARG GLY SEQRES 20 B 353 GLU PHE PHE TYR CYS ASN THR THR GLN LEU PHE ASN ASN SEQRES 21 B 353 THR CYS ILE GLY ASN GLU THR MET LYS GLY CYS ASN GLY SEQRES 22 B 353 THR ILE THR LEU PRO CYS LYS ILE LYS GLN ILE ILE ASN SEQRES 23 B 353 MET TRP GLN GLY THR GLY GLN ALA MET TYR ALA PRO PRO SEQRES 24 B 353 ILE ASP GLY LYS ILE ASN CYS VAL SER ASN ILE THR GLY SEQRES 25 B 353 ILE LEU LEU THR ARG ASP GLY GLY ALA ASN ASN THR SER SEQRES 26 B 353 ASN GLU THR PHE ARG PRO GLY GLY GLY ASN ILE LYS ASP SEQRES 27 B 353 ASN TRP ARG SER GLU LEU TYR LYS TYR LYS VAL VAL GLN SEQRES 28 B 353 ILE GLU MODRES 4I54 ASN B 386 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 386 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 295 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 276 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 262 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 295 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 234 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 355 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 448 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 289 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 276 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 262 ASN GLYCOSYLATION SITE MODRES 4I54 ASN A 334 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 241 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 289 ASN GLYCOSYLATION SITE MODRES 4I54 ASN B 234 ASN GLYCOSYLATION SITE HET 1C1 A 501 28 HET EPE A 502 15 HET NAG A 503 14 HET NAG A 504 14 HET NAG A 505 14 HET NAG A 506 14 HET NAG A 507 14 HET NAG A 508 14 HET NAG A 509 14 HET NAG A 510 14 HET 1C1 B 501 28 HET NAG B 502 14 HET NAG B 503 14 HET NAG B 504 14 HET NAG B 505 14 HET NAG B 506 14 HET NAG B 507 14 HET NAG B 508 14 HET NAG B 509 14 HET EPE B 510 15 HETNAM 1C1 AMINO({[(1R,2R)-1-({[(4-CHLORO-3-FLUOROPHENYL) HETNAM 2 1C1 AMINO](OXO)ACETYL}AMINO)-2,3-DIHYDRO-1H-INDEN-2- HETNAM 3 1C1 YL]METHYL}AMINO)METHANIMI NIUM HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN 1C1 [AMINO({[(1R,2R)-1-{[(4-CHLORO-3- FLUOROPHENYL) HETSYN 2 1C1 CARBAMOYL]FORMAMIDO}-2,3-DIHYDRO-1H- INDEN-2- HETSYN 3 1C1 YL]METHYL}AMINO)METHYLIDENE]AZANIUM HETSYN EPE HEPES HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 1C1 2(C19 H20 CL F N5 O2 1+) FORMUL 4 EPE 2(C8 H18 N2 O4 S) FORMUL 5 NAG 16(C8 H15 N O6) FORMUL 23 HOH *25(H2 O) HELIX 1 1 GLU A 64 CYS A 74 1 11 HELIX 2 2 ASN A 98 LEU A 116 1 19 HELIX 3 3 GLY A 335 PHE A 353 1 19 HELIX 4 4 ASP A 368 MET A 373 1 6 HELIX 5 5 THR A 387 ILE A 396 5 10 HELIX 6 6 ILE A 475 TYR A 484 1 10 HELIX 7 7 GLU B 64 CYS B 74 1 11 HELIX 8 8 TRP B 96 ASN B 98 5 3 HELIX 9 9 ASN B 99 LEU B 116 1 18 HELIX 10 10 GLY B 335 PHE B 353 1 19 HELIX 11 11 ASP B 368 MET B 373 1 6 HELIX 12 12 THR B 387 PHE B 391 5 5 HELIX 13 13 ASN B 392 ILE B 396 5 5 HELIX 14 14 ASN B 474 TYR B 484 1 11 SHEET 1 A 5 TRP A 45 ASP A 47 0 SHEET 2 A 5 TYR A 486 ILE A 491 -1 O GLN A 490 N LYS A 46 SHEET 3 A 5 TYR A 223 CYS A 228 -1 N LEU A 226 O LYS A 487 SHEET 4 A 5 VAL A 242 VAL A 245 -1 O SER A 243 N LYS A 227 SHEET 5 A 5 ILE A 84 LEU A 86 -1 N ILE A 84 O SER A 244 SHEET 1 B 3 VAL A 75 PRO A 76 0 SHEET 2 B 3 PHE A 53 SER A 56 1 N SER A 56 O VAL A 75 SHEET 3 B 3 HIS A 216 CYS A 218 -1 O HIS A 216 N ALA A 55 SHEET 1 C 2 GLU A 91 ASN A 94 0 SHEET 2 C 2 THR A 236 CYS A 239 -1 O GLY A 237 N PHE A 93 SHEET 1 D 4 ILE A 201 LYS A 202 0 SHEET 2 D 4 VAL A 120 LEU A 122 -1 N LYS A 121 O ILE A 201 SHEET 3 D 4 GLN A 432 MET A 434 -1 O MET A 434 N VAL A 120 SHEET 4 D 4 ILE A 423 ASN A 425 -1 N ILE A 424 O ALA A 433 SHEET 1 E 5 LEU A 259 LEU A 261 0 SHEET 2 E 5 ILE A 443 ARG A 456 -1 O THR A 450 N LEU A 260 SHEET 3 E 5 ILE A 284 ARG A 298 -1 N CYS A 296 O CYS A 445 SHEET 4 E 5 ASN A 465 PRO A 470 0 SHEET 5 E 5 THR A 358 PHE A 361 1 N ILE A 360 O PHE A 468 SHEET 1 F 7 ILE A 271 ARG A 273 0 SHEET 2 F 7 ILE A 284 ARG A 298 -1 O ILE A 285 N ARG A 273 SHEET 3 F 7 ILE A 443 ARG A 456 -1 O CYS A 445 N CYS A 296 SHEET 4 F 7 LYS A 328 ASN A 334 0 SHEET 5 F 7 THR A 413 LYS A 421 -1 O LEU A 416 N CYS A 331 SHEET 6 F 7 GLU A 381 CYS A 385 -1 N TYR A 384 O LYS A 419 SHEET 7 F 7 HIS A 374 CYS A 378 -1 N CYS A 378 O GLU A 381 SHEET 1 G 5 TRP B 45 ASP B 47 0 SHEET 2 G 5 TYR B 486 ILE B 491 -1 O GLN B 490 N LYS B 46 SHEET 3 G 5 TYR B 223 CYS B 228 -1 N LEU B 226 O LYS B 487 SHEET 4 G 5 VAL B 242 VAL B 245 -1 O VAL B 245 N ILE B 225 SHEET 5 G 5 ILE B 84 HIS B 85 -1 N ILE B 84 O SER B 244 SHEET 1 H 3 VAL B 75 PRO B 76 0 SHEET 2 H 3 PHE B 53 SER B 56 1 N CYS B 54 O VAL B 75 SHEET 3 H 3 HIS B 216 CYS B 218 -1 O CYS B 218 N PHE B 53 SHEET 1 I 2 PHE B 93 ASN B 94 0 SHEET 2 I 2 THR B 236 GLY B 237 -1 O GLY B 237 N PHE B 93 SHEET 1 J 4 ILE B 201 LYS B 202 0 SHEET 2 J 4 VAL B 120 LEU B 122 -1 N LYS B 121 O ILE B 201 SHEET 3 J 4 GLN B 432 MET B 434 -1 O GLN B 432 N LEU B 122 SHEET 4 J 4 ILE B 423 ASN B 425 -1 N ILE B 424 O ALA B 433 SHEET 1 K 5 LEU B 259 LEU B 261 0 SHEET 2 K 5 ILE B 443 ASP B 457 -1 O THR B 450 N LEU B 260 SHEET 3 K 5 ILE B 284 ARG B 298 -1 N ILE B 294 O SER B 447 SHEET 4 K 5 ASN B 465 PRO B 470 0 SHEET 5 K 5 THR B 358 PHE B 361 1 N ILE B 360 O GLU B 466 SHEET 1 L 7 ILE B 271 ARG B 273 0 SHEET 2 L 7 ILE B 284 ARG B 298 -1 O HIS B 287 N ILE B 271 SHEET 3 L 7 ILE B 443 ASP B 457 -1 O SER B 447 N ILE B 294 SHEET 4 L 7 LYS B 328 ASN B 334 0 SHEET 5 L 7 THR B 413 ILE B 420 -1 O LEU B 416 N CYS B 331 SHEET 6 L 7 GLU B 381 CYS B 385 -1 N TYR B 384 O LYS B 419 SHEET 7 L 7 HIS B 374 CYS B 378 -1 N PHE B 376 O PHE B 383 SSBOND 1 CYS A 54 CYS A 74 1555 1555 2.04 SSBOND 2 CYS A 119 CYS A 205 1555 1555 2.04 SSBOND 3 CYS A 218 CYS A 247 1555 1555 2.04 SSBOND 4 CYS A 228 CYS A 239 1555 1555 2.06 SSBOND 5 CYS A 296 CYS A 331 1555 1555 2.03 SSBOND 6 CYS A 378 CYS A 445 1555 1555 2.04 SSBOND 7 CYS A 385 CYS A 418 1555 1555 2.04 SSBOND 8 CYS B 54 CYS B 74 1555 1555 2.04 SSBOND 9 CYS B 119 CYS B 205 1555 1555 2.03 SSBOND 10 CYS B 218 CYS B 247 1555 1555 2.05 SSBOND 11 CYS B 228 CYS B 239 1555 1555 2.03 SSBOND 12 CYS B 296 CYS B 331 1555 1555 2.04 SSBOND 13 CYS B 378 CYS B 445 1555 1555 2.03 SSBOND 14 CYS B 385 CYS B 418 1555 1555 2.03 LINK ND2 ASN A 234 C1 NAG A 503 1555 1555 1.44 LINK ND2 ASN A 262 C1 NAG A 504 1555 1555 1.45 LINK ND2 ASN A 276 C1 NAG A 505 1555 1555 1.44 LINK ND2 ASN A 289 C1 NAG A 506 1555 1555 1.52 LINK ND2 ASN A 295 C1 NAG A 507 1555 1555 1.44 LINK ND2 ASN A 334 C1 NAG A 508 1555 1555 1.45 LINK ND2 ASN A 355 C1 NAG A 509 1555 1555 1.56 LINK ND2 ASN A 386 C1 NAG A 510 1555 1555 1.44 LINK ND2 ASN B 234 C1 NAG B 502 1555 1555 2.01 LINK ND2 ASN B 241 C1 NAG B 508 1555 1555 1.45 LINK ND2 ASN B 262 C1 NAG B 503 1555 1555 1.44 LINK ND2 ASN B 276 C1 NAG B 504 1555 1555 1.45 LINK ND2 ASN B 289 C1 NAG B 505 1555 1555 1.45 LINK ND2 ASN B 295 C1 NAG B 506 1555 1555 1.44 LINK ND2 ASN B 386 C1 NAG B 507 1555 1555 1.44 LINK ND2 ASN B 448 C1 NAG B 509 1555 1555 1.45 CRYST1 65.324 68.775 94.443 90.00 90.89 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015308 0.000000 0.000238 0.00000 SCALE2 0.000000 0.014540 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010590 0.00000